{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:22:23Z","timestamp":1788355343551,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.transproceed.2011.05.050","type":"journal-article","created":{"date-parts":[[2011,9,11]],"date-time":"2011-09-11T15:10:34Z","timestamp":1315753834000},"page":"2630-2635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Influence of Cytomegalovirus Infections on Patient and Renal Graft Outcome: A 3-year, Multicenter, Observational Study (Post-ECTAZ Study)"],"prefix":"10.1016","volume":"43","author":[{"given":"R.","family":"Abou-Ayache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"B\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Le Pogamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-F.","family":"Westeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Le Meur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hurault de Ligny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Toupance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sinnasse-Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Touchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2011.05.050_bib1","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/ndt\/gfm873","article-title":"CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A","volume":"23","author":"Abou-Ayache","year":"2008","journal-title":"Nephrol Dialys Transplant"},{"key":"10.1016\/j.transproceed.2011.05.050_bib2","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.transproceed.2007.08.040","article-title":"Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients","volume":"39","author":"Naumnik","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.050_bib3","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.transproceed.2005.10.074","article-title":"Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients","volume":"37","author":"Bordils","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.050_bib4","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMc0805714","article-title":"Long-term results of rabbit antithymocyte globulin and basiliximab induction","volume":"359","author":"Brennan","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2011.05.050_bib5","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.transproceed.2006.06.133","article-title":"Long-term results of monoclonal anti-IL2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation","volume":"38","author":"Al Najjar","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.050_bib6","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.transproceed.2009.07.027","article-title":"Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors","volume":"41","author":"Taherimahmoudi","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.050_bib7","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2011.05.050_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.05.050_bib9","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/01.tp.0000230459.22968.26","article-title":"Benefits of cytomegalovirus prophylaxis in solid organ transplantation","volume":"82","author":"Pescovitz","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.050_bib10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.transproceed.2009.01.067","article-title":"Prevention of cytomegalovirus disease in renal transplantation: single-center experience","volume":"41","author":"Parreira","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.050_bib11","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.transproceed.2006.07.001","article-title":"Cytomegalovirus prophylaxis with intravenous polyvalent Immunoglobulin in high-risk renal transplant recipients","volume":"38","author":"Leroy","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.050_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00007890-199304000-00032","article-title":"Cytomegalovirus infection, an etiological factor for acute rejection?","volume":"55","author":"Pouteil-Noble","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.050_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1432-2277.2000.tb01019.x","article-title":"Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analysis","volume":"13","author":"Toupance","year":"2000","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2011.05.050_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1034\/j.1600-6143.2002.20907.x","article-title":"The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients","volume":"2","author":"Sagedal","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.05.050_bib15","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1681\/ASN.V1281758","article-title":"Mycophenolate mofetil does not modify the incidence of cytomegalovirus disease after kidney transplantation but prevents CMV-induced chronic graft dysfonction","volume":"12","author":"Giral","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2011.05.050_bib16","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/00007890-199912270-00011","article-title":"Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients","volume":"68","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.050_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival","volume":"66","author":"Sagedal","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2011.05.050_bib18","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1600-6143.2004.00451.x","article-title":"Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.05.050_bib19","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.tp.0000226071.12562.1a","article-title":"Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis","volume":"81","author":"Limaye","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.050_bib20","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.transproceed.2009.01.085","article-title":"Prognostic effect of lymphocyte subgroup CD4+ and CD8+ cells in peripheral blood in renal transplant patients with cytomegalovirus viremia","volume":"41","author":"Chen","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.050_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2796.2006.01618.x","article-title":"Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?","volume":"259","author":"S\u00f6derberg-Naucler","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.transproceed.2011.05.050_bib22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/514142","article-title":"Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease","volume":"176","author":"Manez","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transproceed.2011.05.050_bib23","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ndt\/gfi033","article-title":"Is there a link between cytomegalovirus infection and new-onset posttransplantation diabete mellitus?","volume":"20","author":"Hjelmesaeth","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2011.05.050_bib24","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.transproceed.2009.07.024","article-title":"Cytomegalovirus-induced adrenal insufficiency in a renal transplant recipient","volume":"41","author":"Ardalan","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.050_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-6143.2003.30114.x","article-title":"Determinants of cardiovascular mortality after renal transplantation: a role for cytomegalovirus?","volume":"3","author":"Kalil","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.05.050_bib26","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.transproceed.2005.08.058","article-title":"Cytomegalovirus replication and \u201cherpesvirus burden\u201d as risk factor of cardiovascular events in the first year after renal transplantation","volume":"37","author":"G\u00f3mez","year":"2005","journal-title":"Transplantation Proc"},{"key":"10.1016\/j.transproceed.2011.05.050_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00007890-200007270-00013","article-title":"Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease","volume":"70","author":"Humar","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.050_bib28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/clinids\/23.3.468","article-title":"Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients","volume":"23","author":"Falagas","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2011.05.050_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9343(97)80021-6","article-title":"The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients","volume":"103","author":"George","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.transproceed.2011.05.050_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1681\/ASN.V124848","article-title":"Cytomegalovirus in renal transplantation","volume":"12","author":"Brennan","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2011.05.050_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.femsre.2003.07.005","article-title":"Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression","volume":"28","author":"Cinati","year":"2004","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.transproceed.2011.05.050_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0609.2005.00601.x","article-title":"Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation","volume":"76","author":"Bruno","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.transproceed.2011.05.050_bib33","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1086\/342911","article-title":"The pathogenesis of hepatitis C virus is influenced by cytomegalovirus","volume":"35","author":"Razonable","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451100861X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451100861X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:27:28Z","timestamp":1758576448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113451100861X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S004113451100861X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2011.05.050","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Influence of Cytomegalovirus Infections on Patient and Renal Graft Outcome: A 3-year, Multicenter, Observational Study (Post-ECTAZ Study)","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2011.05.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}